These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9886618)

  • 1. Enzyme-linked immunosorbent assay detection of prostate-specific antigen messenger ribonucleic acid in prostate cancer.
    Hoshi S; Kobayashi S; Takahashi T; Suzuki KI; Kawamura S; Satoh M; Chiba Y; Orikasa S
    Urology; 1999 Jan; 53(1):228-35. PubMed ID: 9886618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of PSA mRNA from the peripheral blood and pelvic lymph nodes in patients with prostatic cancer by means of reverse transcription-polymerase chain reaction (RT-PCR)].
    Mao H; Hoshi S; Takahashi T; Kaneda T; Wang J; Suzuki K; Orikasa S
    Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):596-603. PubMed ID: 9666686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic diagnosis of pelvic lymph node metastasis using fine needle aspiration samples in prostate cancer].
    Hoshi S; Orikasa S; Takahashi T; Suzuki K; Kaneda T; Saitoh H; Yoshikawa K; Ono K; Hikichi Y; Ohkawa A; Funato T
    Hinyokika Kiyo; 1996 Oct; 42(10):781-5. PubMed ID: 8951475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
    Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic diagnosis of pelvic lymph node metastasis in prostate cancer using aspiration biopsy samples].
    Takahashi T; Hoshi S; Kaneda T; Mou K; Orikasa S; Ohkawa A; Funato T; Sasaki T; Kimura N
    Rinsho Byori; 1996 Dec; 44(12):1183-8. PubMed ID: 8990938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of PSA gene expression on urogenital cell lines.
    Takahashi T; Hoshi S; Satoh M; Kaneda T; Suzuki KI; Nakagawara KI; Orikasa S
    Int J Urol; 1999 Oct; 6(10):526-31. PubMed ID: 10533904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format.
    Emmanouilidou E; Ioannou PC; Christopoulos TK; Polizois K
    Anal Biochem; 2003 Feb; 313(1):97-105. PubMed ID: 12576064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.
    Moreno JG; O'Hara SM; Long JP; Veltri RW; Ning X; Alexander AA; Gomella LG
    Urology; 1997 Apr; 49(4):515-20. PubMed ID: 9111619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate specific antigen messenger RNA from pelvic lymph node in prostate cancer.
    Hoshi S; Orikasa S; Takahashi T; Kaneda T; Mao H; Ohkawa A; Funatob T; Kimura N
    Urol Oncol; 1997; 3(5-6):183-8. PubMed ID: 21227143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
    Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
    Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
    Gelmini S; Tricarico C; Petrone L; Forti G; Amorosi A; Dedola GL; Serio M; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2003 Mar; 41(3):261-5. PubMed ID: 12705330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
    Gao CL; Maheshwari S; Dean RC; Tatum L; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    Urology; 1999 Apr; 53(4):714-21. PubMed ID: 10197846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.
    Schamhart D; Swinnen J; Kurth KH; Westerhof A; Kusters R; Borchers H; Sternberg C
    Clin Chem; 2003 Sep; 49(9):1458-66. PubMed ID: 12928226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.